StockData

VitaSpring Biomedical Co. Ltd. (VSBC) stock

VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.58MP/E –Yield –

VitaSpring Biomedical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

VitaSpring Biomedical's operating income for the twelve months ending Jul 31, 2026 was -$454.86K. For fiscal 2026 it was -$385.41K. The highest annual figure on record is $1.13M in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2026Jan 31, 2026-$385.41K–
FY2025Jan 31, 2025-$679.91K–
FY2024Jan 31, 2024-$1.12M–
FY2023Jan 31, 2023-$4.18M-470.8%
FY2022Jan 31, 2022$1.13M+164.9%
FY2021Jan 31, 2021$425.38K+6048.0%
FY2020Jan 31, 2020$6.92K–
FY2019Jan 31, 2019-$22.40K–
FY2018Jan 31, 2018-$6.37K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2027CQ2 2026Jul 31, 2026-$161.82K–
Q1 FY2027CQ1 2026Apr 30, 2026-$75.84K–
Q4 FY2026CQ4 2025Jan 31, 2026-$81.46K–
Q3 FY2026CQ3 2025Oct 31, 2025-$135.73K–
Q2 FY2026CQ2 2025Jul 31, 2025-$99.07K–
Q1 FY2026CQ1 2025Apr 30, 2025-$69.15K–
Q4 FY2025CQ4 2024Jan 31, 2025-$126.49K–
Q3 FY2025CQ3 2024Oct 31, 2024-$117.93K–
Q2 FY2025CQ2 2024Jul 31, 2024-$218.66K–
Q1 FY2025CQ1 2024Apr 30, 2024-$216.83K–
Q4 FY2024CQ4 2023Jan 31, 2024-$225.40K–
Q3 FY2024CQ3 2023Oct 31, 2023-$234.98K–
Q2 FY2024CQ2 2023Jul 31, 2023-$353.58K–
Q1 FY2024CQ1 2023Apr 30, 2023-$304.60K-188.8%
Q4 FY2023CQ4 2022Jan 31, 2023-$4.16M-393.3%
Q3 FY2023CQ3 2022Oct 31, 2022-$183.22K-233.3%
Q2 FY2023CQ2 2022Jul 31, 2022-$174.51K-169.6%
Q1 FY2023CQ1 2022Apr 30, 2022$343.13K+91.3%
Q4 FY2022CQ4 2021Jan 31, 2022$1.42M+151.0%
Q3 FY2022CQ3 2021Oct 31, 2021$137.45K–
Q2 FY2022CQ2 2021Jul 31, 2021$250.88K–
Q1 FY2022CQ1 2021Apr 30, 2021$179.41K–
Q4 FY2021CQ4 2020Jan 31, 2021$565.53K–
Q3 FY2021CQ3 2020Oct 31, 2020-$31.79K-163.0%
Q2 FY2021CQ2 2020Jul 31, 2020-$90.62K–
Q1 FY2021CQ1 2020Apr 30, 2020-$17.75K–
Q4 FY2020CQ4 2019Jan 31, 2020-$35.79K-818.8%
Q3 FY2020CQ3 2019Oct 31, 2019$50.45K–
Q2 FY2020CQ2 2019Jul 31, 2019-$6.15K–
Q1 FY2020CQ1 2019Apr 30, 2019-$8.51K–
Q1 FY2019CQ1 2018Apr 30, 2018$4.98K–

More VitaSpring Biomedical figures

See a number that looks wrong?